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Available online 19 August 2016Consumption of foods containing chicken liver has been associatedwith Campylobacter enteritis. Campylobacters
can contaminate the surface of livers post-mortembut can also arise through systemic infectionof colonising bac-
teria in live birds. The use of bacteriophage to reduce levels of Campylobacter entering the food chain is a prom-
ising intervention approach but most phages have been isolated from chicken excreta. This study examined the
incidence and contamination levels of Campylobacter and their bacteriophage inUK retail chicken liver. Using en-
richment procedures, 87% of 109 chicken liverswere surface contaminatedwith Campylobacter and 83% contam-
inatedwithin internal tissues. Direct plating on selective agar allowed enumeration of viable bacteria from43% of
liver sampleswith counts ranging from 1.8–N3.8 log10 CFU/cm2 for surface samples, and 3.0–N3.8 log10 CFU/g for
internal tissue samples. Three C. jejuni isolates recovered from internal liver tissueswere assessed for their ability
to colonise the intestines and extra-intestinal organs of broiler chickens following oral infection. All isolates efﬁ-
ciently colonised the chicken intestines butwere variable in their abilities to colonise extra-intestinal organs. One
isolate, CLB104, could be recovered by enrichment from the livers and kidneys of three of seven chickens. Cam-
pylobacter isolates remained viable within fresh livers stored at 4 °C over 72 h and frozen livers stored at−20 °C
over 7 days in atmospheric oxygen, and therefore constitute a risk to human health. Only three Campylobacter-
speciﬁc bacteriophages were isolated, and these exhibited a limited host range against the Camplylobacter chick-
en liver isolates. All were identiﬁed as group III virulent bacteriophage based on their genome size of 140 kb. The
application of broad host range group II virulent phages (8 log10 PFU/g) to liver homogenates containing C. jejuni
strains of diverse origin at 4 °C resulted inmodest but signiﬁcant reductions in the viable counts ranging from0.2
to 0.7 log10 CFU/g.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Keywords:
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Chicken
Liver
Bacteriophage
Food safety
Phage therapy1. Introduction
Following emergence as an enteric pathogen in 1970s (Skirrow,
1977), Campylobacter has been a major concern worldwide. In the UK,
Campylobacter is the most common bacterial cause of gastrointestinal
infection recorded in the last two decades (Adak et al., 2005; Food
Standards Agency, 2013). The total number of cases of Campylobacter
infection during 2000–2012 was 781,581, from 1,052,581 laboratory
conﬁrmed cases of foodborne disease (Food Standards Agency, 2013).
Campylobacteriosis is the most frequently reported foodborne disease
but these ﬁgures belie actual unreported caseloads that are estimated
to be 9million and 1.3million cases per yearwithin the EU and USA, re-
spectively (Centers for Disease Control and Prevention, CDC, 2014;
EFSA, 2015).
The primary source of the major pathogenic species, C. jejuni and C.
coli, are contaminated chicken and cattle meat (Adak et al., 2005;Connerton).
. This is an open access article underSuzuki and Yamamoto, 2009; Wilson et al., 2008), whereas less fre-
quently they arise from wildlife (Hughes et al., 2009; Sippy et al.,
2012), water, sewage and the environment (Jones, 2001; Waage et al.,
1999). These bacteria are prevalent in offal, and in particular chicken
liver (Cornelius et al., 2005, Kenar et al., 2009; Noormohamed and
Fakhr, 2012; Noormohamed and Fakhr, 2013; Strachan et al., 2012;
Vashin et al., 2009; Whyte et al., 2006). Dishes such as liver paté and
liver parfait have been reported as potential transmission vehicles for
outbreaks of foodborne disease (Centers for Disease Control and
Prevention, CDC, 2013; Edwards et al., 2014; Hope et al., 2014; Inns et
al., 2010; O'Leary et al., 2009; Wensley and Coole, 2013) and the num-
ber of cases is increasing (Little et al., 2010). Moreover, their presence
could pose a risk to animal welfare as Campylobacter species have
been associated with a disease affecting poultry liver termed vibrionic
hepatitis (Crawshaw et al., 2015; Jennings et al., 2011; Stephens et al.,
1998).
In some cases, the occurrence of Campylobacter in liver may be the
result of contamination from the intestinal contents during processing
(Barot et al., 1983). Nonetheless, isolation from the internal tissue ofthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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gans (Cox et al., 2007). It has been recognised that bacteria can cross the
intestinal barrier of animals and humans, a process known as bacterial
translocation. In general, the lymphatic path is perceived as the more
convincing primary route of the translocation as compared with the ve-
nous system (Balzan et al., 2007). In vitro studies have demonstrated
that Campylobacters can translocate using either transcellular passage
through the enterocytes or paracellular routes via the tight junctions
(Backert et al., 2013). Speciﬁc translocationmechanisms have been elu-
cidated for enteric pathogens such as Salmonella, which uses several
routes to pass through the intestinal barrier to inhabit systemic organs
(Watson and Holden, 2010). However, further studies are required to
obtain evidence of the translocation mechanisms operating for
Campylobacters in humans and animals (Backert et al., 2013). For exam-
ple, the capacity of C. jejuni to colonise particular tissues is affected by
the organism's ability to utilise speciﬁc nutrients - asparagine utilisation
has been reported to improve the ability of the pathogen to colonise
liver (Hofreuter et al., 2008).
Thorough cooking is the key to eliminating the risk of Campylobacter
enteritis from poultry dishes. However, recipes for meals such as liver
paté indicate minimal cooking to preserve the sensory properties and
retain a pink appearance inside. To safely cook such dishes, critical
core temperatures of 68–70 °C must be reached and held for periods
as long as 45min (Hutchison et al., 2015), which can result in unaccept-
able sensory characteristics (Whyte et al., 2006). Pre-cooking treat-
ments could be applied to lower the initial contamination level, for
instance by freezing and washing of the liver using organic acid
(Harrison et al., 2013; Hutchison et al., 2015). However, the use of or-
ganic acid was found to cause a colour change or bleaching of the liver
surface, and may not be effective for Campylobacter naturally present
within the internal structures of the liver.
Bacteriophages have gained recognition as therapeutic agents to
control pathogens in livestock and poultry (reviewed by Johnson et al.,
2008), and represent a potential approach to control Campylobacters
in livers. Campylobacter bacteriophages can be isolated from chicken
meat and chicken excreta (Atterbury et al., 2003, 2005; El-Shibiny et
al., 2005; Loc Carrillo et al., 2007) but to date attempts to isolate Cam-
pylobacter phages from chicken liver have not been reported. The appli-
cation of a single dose or mixtures of Campylobacter phages have been
reported to be effective in reducing the intestinal colonisation of
chickens by C. jejuni and C. coli (El-Shibiny et al., 2009; Kittler et al.,
2013; Loc Carrillo et al., 2005). The efﬁcacy of the treatment varies de-
pending on the phage type and dose, the phage-sensitivity of the host,
the time interval post administration (Loc Carrillo et al., 2005) and the
route of administration, i.e. by oral gavage or via chicken feed
(Carvalho et al., 2010). Phage resistant Campylobacter have been report-
ed post-treatment at relatively low frequencies of 2–4% (El-Shibiny et
al., 2009; Hammerl et al., 2014; Loc Carrillo et al., 2005).
In this study, Campylobacter and their phages were isolated from re-
tail chicken liver. Campylobacter isolates were tested for their ability to
re-colonise extra-intestinal organs of chickens in order to identify
Campylobacter isolates able to inhabit the liver of broiler chickens. Final-
ly, virulent bacteriophages were applied to Campylobacter contaminat-
ed chicken liver homogenates to provide proof of principle that
bacteriophages can reduce Campylobacter contamination within the
liver matrix.
2. Material and methods
2.1. Bacterial strains and bacteriophage
Campylobacter jejuni PT14 (Brathwaite et al., 2013)wasused as a ref-
erence strain and also for phage isolation and propagation. Campylobacter
jejuni HPC5 (Loc Carrillo et al., 2005) and C. jejuni 81–176 (Korlath et al.,
1985) were used as controls in the chicken colonisation experiments
and the phage treatments of contaminated chicken livers. AllCampylobacter isolates were cultured on blood agar base no. 2 CM0271
(Oxoid, Basingstoke, United Kingdom) supplementedwith 5% deﬁbrinat-
ed horse blood (TCS, Buckingham, United Kingdom) under microaerobic
conditions (5% O2, 5% H2, 10% CO2, 80% N2) at 42 °C for 18–24 h. Cam-
pylobacter phages CP30A (GenBank accession number JX569801) and
CPX (GenBank accession number JN132397)were propagated on C. jejuni
PT14 or a contemporary Campylobacter isolate using the soft agar overlay
method (Atterbury et al., 2003). Phages from the UK typing scheme (ɸ1
to ɸ16) were propagated as described by Frost et al. (1999). In order to
obtain high titre stocks of bacteriophage, 30 ml volumes of plate lysates
were centrifuged at 40,000g for 2 h at 4 °C. The pellets obtained were
re-suspended in 1 ml of SM buffer (50 mM Tris·HCl (pH 7.5), 100 mM
NaCl, 8mMMgSO4, 0.01%Gelatin) to give a phage suspension containing
approximately 10 log10 PFU/ml.
2.2. Preparation of chicken liver
Chicken liver samples were purchased from local supermarkets in
Nottingham and Loughborough in the UK. Samples were kept at 4 °C
and analysed before their expiry date as stated on the packaging. Each
package contained 5–9 livers which were divided into two halves.
Half of the liver was transferred into a stomacher bag (Seward Ltd.,
Worthing, UK) and 10 ml of Maximum Recovery Diluent CM733
(MRD; Oxoid; Basingstoke, UK) was added. The liver was gently mas-
saged to re-suspend Campylobacter on the liver surface. To recover
Campylobacter from internal tissues, the other half of liverwas sterilised
by dipping the liver into boiling water for 20–30 s (Whyte et al., 2006)
and then tissue was excised with hot scalpel before being stomached
with the addition of MRD (1:1 dilution ratio).
2.3. Isolation of Campylobacter from chicken liver
A 4 ml aliquot of suspension from the liver surface sample or the
stomached internal tissue was transferred into 4 ml of enrichment
media. This consisted of 2× Campylobacter Enrichment Broth Lab135
(Lab M, Heywood, UK) made up with the addition of: 10% lysed horse
blood (TCS), 0.25 g/l each of sodium pyruvate, sodium metabisulphite
and ferrous sulphate (each from Sigma Aldrich, Poole, UK) and Campylo-
bacter Enrichment Selectavial SV59 (Mast, Bootle UK), in a bijoux bottle.
The total volume of 8 ml resulted in limited airspace in the bottle, hence
maintainingmicroaerobic conditions during incubation at 37 °C for 48 h.
Five 10 μl aliquots from each bijouxwere dispensed ontomCCDA CM739
agar (Oxoid) prepared with the addition of Campylobacter selective sup-
plement code (SR155, Oxoid) and additional AgarNo. 1 (Oxoid) added to
give 2% and then incubated at 42 °C for 48 h under microaerobic condi-
tions. Campylobacterwere conﬁrmed after subculture, usingmicroscopic
observation of Gram stained cells, together with catalase and oxidase
tests.
2.4. Enumeration of Campylobacter
Campylobacter was enumerated using the Miles and Misra tech-
nique, with serial dilutions prepared in MRD and 10 μl aliquots spotted
in quintuplicate on 2% mCCDA before incubating under microaerobic
conditions at 42 °C for 48 h. Typical Campylobacter colonies were count-
ed and the total number calculated as either log10 CFU/g for internal tis-
sue samples or log10 CFU/cm2 for surface liver samples.
2.5. Species identiﬁcation and Fla-typing using PCR methodologies
CampylobacterDNAwas isolatedusing theGenElute™Bacterial Geno-
mic DNA Kit according to manufacturer's instructions for Gram negative
bacteria (Sigma-Aldrich, UK). The PCR methodology was based on
conditions previously described by Linton et al. (1997) for species identi-
ﬁcation and by Elvers et al. (2008) for FlaA SVR-typing. The oligonucleo-
tides were purchased from Euroﬁns (Ebersberg, Germany) and consisted
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HIP1134R (5′-AGCTAGCTTCGCATAATAACTTG-3′) targeting the C. jejuni
hippuricase gene, CC18F (5′-GGTATGATTTCTACAAAGCGAG-3′) and
CC51R (5′-ATAAAAGACTATCGTCGCGTG-3′) speciﬁc for the C. coli
aspartokinase gene, and FLA4R (5′-GGATTTCGTATTAACACAAATGGTGC-
3′) and FLA625R (5′-CAAG[AT]CCTGTTCC[AT]ACTGAAG) for the
Campylobacter ﬂaA gene. To determine the Fla type of the Campylobacter
isolates, the PCR products were puriﬁed using the Wizard® SV Gel and
PCR Clean-Up System (Promega, Southampton, UK) and the DNA se-
quenced using the Euroﬁns MWG Value Read service.
2.6. Isolation and characterisation of bacteriophages from chicken liver
Bacterial lawns were prepared, plaque puriﬁed and the plaque
forming units perml (PFU/ml) were determined as previously described
(Atterbury et al., 2003). The bacteriophages were diluted to the routine
test dilution of approximately 6 log10 PFU/ml. Ten microliters of phage
suspensions were dispensed onto the surface of the lawns of the test
Campylobacter strain and then incubated under microaerobic conditions
at 42 °C for 18–24 h. The lysis proﬁles of the isolates produced by each
phage were scored according to the protocol described by Frost et al.
(1999) for the UK phage typing scheme. Phage genomic DNAswere pre-
pared as previously described (Loc Carrillo et al., 2007). PCR ampliﬁca-
tion of Campylobacter phage DNAs was performed using group III-
speciﬁc primers CP853B (5′-TCGTTATACCACGGATATAG-3′) and
CP854B (5′-TATAGGAGGGTTGTGAAATG-3′), the ampliﬁcation products
of which can discriminate CP30A and CP8-like bacteriophages (Siringan
et al., 2014).
2.7. Colonisation of chickens with Campylobacter
Procedures for the chicken colonisation experiments were carried
out as previously described (Loc Carrillo et al., 2005). For each
Campylobacter isolate, a suspension of 7 log10 CFU was administered
by oral gavage to seven 16-day-old broiler chickens (male Ross 308)
reared under strict biosecure conditions. The birds were killed after
7 days, and the caecal content, liver, spleen, heart, kidney and breast
meat were examined for the presence of Campylobacter by direct plat-
ing onmCCDA and by enrichment as describe in Section 2.3. These an-
imal studies were conducted under the Animals Scientiﬁc Procedures
Act (1986) and were approved by the University of Nottingham local
ethical review committee.
1.1. Recovery and survival of C. jejuni in fresh and frozen chicken liver
during storage
Campylobacter-free chicken liverswereharvested fromCampylobacter-
negative broiler chickens reared under strict biosecure conditions. Fresh
chicken livers were divided into sections weighing approximately 10 g.
Each section was placed into a stomacher bag and weighed. The liver was
then inoculated with 5 ml C. jejuni suspension containing 3 or
7 log10 CFU/ml, and replaced with sterile water for negative controls. The
samples were stomached and stored at 4 °C for 72 h. Aliquots of 200 μl
were taken for Campylobacter enumeration at 0, 8, 24, 32, 48, 56, and
72 h time intervals over the period. Frozen chicken liver was defrosted for
18 h at 4 °C prior to inoculation and storage at 4 °C or−20 °C. The subse-
quent steps followed the same protocol as fresh liver samples but at daily
intervals over 7 days. Three independent replicate experiments were per-
formed with fresh and frozen livers.Table 1
Prevalence and concentration of Campylobacter in retail chicken liver.
Sample Samples containing Campylobacter Samples with N3.0 log CF
Liver surface 95/109 (87.2%) 3/109 (2.8%)
Internal tissue 90/109 (82.6) 5/109 (4.6%)2.8. Phage treatment of Campylobacter contaminated chicken livers
Campylobacter-free chicken livers (10 g) were stomached before the
addition of C. jejuni suspensions to inoculum densities of approximately
3 log10 CFU/g (low inoculum) or 5 log10 CFU/g (high inoculum). The
liver stomachates containing C. jejuni were treated with either a phage
suspension at 8 log10 PFU/g or with an equivalent volume of SM buffer
(mock treatment). Campylobacters were enumerated and the phage
titred as indicated above, following incubation at 4 °C over 48 h. All ex-
periments were performed in triplicate.
2.9. Statistical treatment of data
Statistical differences between paired control and treatment groups
(using log10-transformed Campylobacter counts) were assessed by
using the Student's t-test with signiﬁcance p b 0.05. Differences be-
tween experimental groups were analysed by analysis of variance.
3. Results
3.1. Prevalence of Campylobacter in retail chicken liver
A total of 109 samples of retail chicken liver were analysed for the
presence of Campylobacter recoverable from surface or internal tissues.
Isolationwas performed on 7 different batcheswithin a 2month period.
There was a high prevalence of Campylobacter with 87.2% and 82.6% of
samples positive from surface and inner tissues respectively (Table 1).
Most samples contained low numbers of Campylobacter that were
only recoverable by enrichment. Samples that could be enumerated
contained Campylobacter in the range of 1.8–3.8 log10 CFU/cm2 for sur-
face samples and 3.0–3.8 log10 CFU/g for internal tissue samples. Three
surface samples and 5 internal tissue samples contained Campylobacter
≥3 log10 CFU/g, which would be considered to pose a signiﬁcant risk to
consumers (Food Safety Agency UK 2014).
3.2. Frequency and characteristics of Campylobacter phages in retail chick-
en liver
Three Campylobacter-speciﬁc bacteriophages were isolated from
109 retail chicken livers (2.7%). One of the phage originated from a sur-
face sample (CLP6), while the other two were from the internal tissues
of the livers (CLP47 and CLP63). Phages CLP47 andCLP63 exhibited sim-
ilar lytic abilities against the C. jejuni liver isolates (64%), whilst phage
CLP6 was virulent against more of the C. jejuni isolates (88%). However,
the host ranges of the three new liver isolates were more speciﬁc than
phages CP30A and CPX previously isolated from chicken intestinal con-
tents or chicken meat respectively. None of the phage isolated from
chicken liver infected the C. coli isolates.
Campylobacter bacteriophages possess double-stranded DNA ge-
nomes that are classiﬁed into three groups according to their genome
size and head diameter, i.e. group I with genome sizes of 320 kb and
head diameters of 140.6 and 143.8 nm; group II, with genome sizes of
184 kb and head diameters of 99 nm; and group III with genome sizes
of 138 kb and head sizes of 100 nm (Sails et al., 1998). PFGE analysis
of bacteriophage genomic DNA revealed that the three phages isolated
from chicken liver were approximately 140 kb in size, which is typical
of group III bacteriophages and similar to the reference phages CP30A
and CPX. PCR ampliﬁcation of the phage DNAs with group III-speciﬁc
primers conﬁrmed the classiﬁcation of the liver phages.U/cm2 or CFU/g Number of C. jejuni isolates Number of C. coli isolates
25/95 (26.3%) 70/95 (73.7%)
37/87 (42.5%) 50/87 (57.5%)
Table 2
Characteristics of Campylobacters isolated from livers.
Isolates Species Fla-Type
Bacteriophage lytic spectraa
CLP6 CLP47 CLP63 CP30A CPX ɸ3 ɸ15
CLB44 C. jejuni 32 OL OL OL OL OL OL OL
CLB56 C. coli 16 – – – – – – –
CLB62 C. jejuni 100 – – – ++ bSCL – –
CLB68 C. jejuni 16 bCL – – bCL – +++ +++
CLB104 C. jejuni 18 – – – – – SCL +++
a Classiﬁcation of phage infection based on that of Frost et al. (1999) using a routine test dilution of 6 log10 PFU/ml: CL conﬂuent lysis; OL opaque lysis; SCL semi-conﬂuent lysis; +++
N100 plaques; ++ b100 N50 plaques; – no plaque formation.
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A combination of Fla-typing and phage typing was used to discrim-
inate the Campylobacter isolates, which enabled them to be placed
into ﬁve groups that are summarised in Table 2. The C. coli isolates rep-
resent a single Fla-type that could not be distinguished with the phage
used in this study. C. jejuni isolates could be placed in four groups
where concordance was observed between the Fla-types and the
phage sensitivity proﬁles. One group, represented by isolate CLB104,
were recovered exclusively from the internal tissues of retail chicken
liver with counts ≥3 log10 CFU/g, and therefore represents a signiﬁcant
risk to human health. C. jejuni isolates CLB44, CLB68 and CLB104 that
originated from the internal tissues of chicken livers were selected for
further study.
1.2. Persistence of C. jejuni and phage in fresh and frozen chicken liver
during storage
Microbiological analysis showed that the caecal contents, internal
organs and breastmeat of the experimental chickenswere Campylobac-
ter-free post-mortem prior to inoculation with test strains. Fresh and
defrosted frozen livers were inoculated with 5 strains of C. jejuni at
two inoculum levels of approximately 7 log10 CFU/g and 3 log10 CFU/g.
The inocula were selected to represent the high and low contamination
levels observed in this study. The recovery of Campylobacter counts
from fresh and frozen livers immediately following inoculation was al-
most 100% demonstrating that the liver stomachates are not inimical
to the survival of Campylobacters. Thereafter C. jejuni (control strains
and liver isolates) remained viable at both inoculation levels throughout
the storage period at 4 °C (Fig. 1). Mean reductions of 0.4–0.5 log10 CFU/g
in the Campylobacter counts were observed for frozen liver samples. The
greatest reduction recorded was 1.0 ± 0.74 log10 CFU/g from the low
level inoculum of C. jejuni CLB44. In contrast, C. jejuni CLB104 showed
no signiﬁcant fall in the count under any circumstance (p N 0.05). AllA
Fig. 1.ViableCampylobacter counts in fresh and frozen chicken liver during storage: A) 72h (fres
or low (3 log10 CFU/g) target inoculums. Error bars represent the standard deviations for n=bacteriophage could be recovered from fresh or frozen liver stomachates
without any signiﬁcant fall in the inoculation titre of 8 log10 PFU/g over
72 h (p N 0.05).3.4. Phage treatment of Campylobacter contaminated liver
As noted above the bacteriophages isolated from liver have a re-
stricted host range amongst the Campylobacter liver isolates compared
to those of chicken intestinal (CP30A) or chicken meat (CPX) origin or
the typing phages ɸ3 and ɸ15 (Table 2). Phages ɸ3 and ɸ15 have tailed
morphologies and are classiﬁed as group II based on their genome sizes
of 180 and 190 kb (Sails et al., 1998). However, ɸ3 and ɸ15were able to
lyse 3 of the 5 groups of Campylobacter liver isolates in addition to the
control C. jejuni strains HPC5 (original source chicken intestine) and
81–176 (original source human with campylobacteriosis), and were
therefore selected for phage therapy (biosanitization) applications
with chicken liver to enable comparisons of the effect between C. jejuni
strains. Phages ɸ3 or ɸ15 were added at 8 log10 PFU/g to liver
stomachates containing either low (3 log10 CFU/g) or high
(5 log10 CFU/g) target Campylobacter inoculums and stored at 4 °C
over 48 h. Fig. 2 presents the viable counts of ﬁve C. jejuni strains follow-
ing either mock or phage treatments of chicken liver suspensions. All
the phage treated C. jejuni strains showed a signiﬁcant reduction in
the viable count compared to the control for low and high inoculums
(p b 0.05). However, the reductions observed were modest. For exam-
ple, the reductions in viable count recorded for the high risk livers rep-
resented by the high inoculum series of 5 log10 CFU/g ranged between
0.7 log10 CFU/g for the chicken liver isolate CLB68 treated with ɸ15
and 0.2 log10 CFU/g for the chicken intestinal isolate HPC5 treated
with either ɸ3 or ɸ15. The phage recovered from these experiments
showedminimal variation in titre and showed no signiﬁcant difference
to the initial inoculum titre (p N 0.05).B
h liver at 4 °C) and B)7 days (frozen liver at−20 °C)with either initial high (7 log10 CFU/g)
3.
A B
Fig. 2. Phage activity against ﬁve C. jejuni strains in chicken liver: A) high contamination (5 log10 CFU/g) and B) low contamination levels (3 log10 CFU/g). Campylobacter-free liver samples
were prepared by addition of Campylobacter suspensions after which, each was treated with either a phage suspension or with SM buffer (mock treatment). Campylobacters were
enumerated following incubation at 4 °C for 48 h. White columns represent mock-treated samples, grey columns represent ɸ3 treatments and black columns represent ɸ15
treatments. Error bars represent the standard deviations for n= 3.
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Cell suspensions of ﬁve C. jejuni cultures in physiological phosphate
buffered saline (approximately 7 log10 CFU/ml)were administered oral-
ly, to 6 or 7 broiler chickens and colonisation was established after
7 days by examining post-mortem Campylobacter counts from chicken
caecal contents and from extra-intestinal organs, i.e. liver, heart, spleen,
breastmuscle and kidney. Therewas no observable pathology for any of
the organs. All chickens contained high counts of Campylobacter in their
caecal contents (N7 log10 CFU/g) based on enumeration on mCCDA
plates (Table 3). However, Campylobacters could only be recovered
from the extra-intestinal organs of chickens colonised by the liver iso-
lates, and only by enrichment. C. jejuni isolate CLB104 was detected in
the liver and kidney 3 of 7 chickens, while being recovered from all of
the extra-intestinal organs of one bird. No Campylobacterswere recov-
ered from the excised breast meat of any chicken. No Campylobacters
were recovered from the extra-intestinal organs of the control C. jejuni
strains HPC5 or 81–176.4. Discussion
Campylobacterwas found in themajority of retail chicken liver sam-
ples at varying levels of contamination. Of concern are chicken meat
samples containing N3.0 log CFU/g, which pose a disproportionally
high risk to consumer health (Food Standards Agency, 2015). However,
we recorded Campylobacter counts N3.0 log CFU/g for 2.8% of the surface
and 4.6% of the internal tissue samples from retail chicken livers. A com-
pilation of ﬁndings presented herewith those available in the literature,
are presented in Table 4, which demonstrates that Campylobacter con-
tamination of livestock liver is prevalent with surveys recording that
66–100% of the samples tested were positive. In the majority of cases
the livers showed a low level contamination, for example, Cornelius et
al. (2005) andWhyte et al. (2006) found that 83–88% of internal tissues
of livers harboured b102MPN (most probable number) per g, while the
remaining samples contained 102–103 MPN/g. A clear dose–response
relationship between consumption of chicken liver paté and the risk
of infection with Campylobacter has been demonstrated (Edwards et
al., 2014). A low level of contamination does not eliminate the risk ofTable 3
Recovery of Campylobacter from chicken intestines and extra-intestinal organs.
Campylobacter isolates Caecal content (log10 CFU/g)
Recovery by en
Liver
CLB44 7.7 ± 0.82 2/6 (33%)
CLB68 8.0 ± 0.37 1/7 (14%)
CLB104 7.5 ± 0.43 3/7 (43%)
HPC5 7.4 ± 0.70 0/7 (0%)
81–176 7.2 ± 0.47 0/7 (0%)Campylobacter infection since the infective dose can be as low as 500
cells (Robinson, 1981).
Whilst Campylobacters are frequently reported from liver, this is the
ﬁrst study to report the isolation of Campylobacter-speciﬁc bacterio-
phage. The isolation frequency was comparatively low at 2.7% but the
phages recovered were generally able to infect the Campylobacters re-
covered from liver suggesting they are replicating in the source tissues.
This would offer the prospect that phage therapy could be applied
to control Campylobacters in vivo or on retail liver. The application of
Campylobacter-speciﬁc bacteriophages has been demonstrated to suc-
cessfully reduce contamination levels in chicken skin and meat
(Atterbury et al., 2003, Bigwood et al., 2008; Goode et al., 2003). Similar-
ly the application of phages ɸ3 and ɸ15 to chicken liver stomachates
containingC. jejuni resulted in signiﬁcant reductions in the viable counts
of all ﬁve strains tested. However, the reductions observed post phage
treatment in this study are unlikely to have a universal impact on the
risk imparted by the consumption of chicken liver. As discussed above
chicken meat containing N3 log10 CFU/g represents a disproportionate
risk, and viable count reductions in the range of 0.2 to 0.7 log10 CFU/g
for the high level contamination series of 5 log10 CFU/g would not be
sufﬁcient to reduce the risk of infection. Whereas reductions of
0.7 log10 CFU/g in the viable count for lower levels of contamination,
as demonstrated in the 3 log10 CFU/g series experiments in this study,
could be of beneﬁt. For the application to be of general use the levels
of pathogen reduction need to be uniformly at the higher levels ob-
served here, and the application would have to be on the liver before
any processing for cooking and consumption. Bacteriophages in general
have gained support for food sanitisation applications since bacterio-
phage capable of lysing the foodborne pathogens Listeriamonocytogenes
or Salmonella have been approved in the USA (US Food and Drug Ad-
ministration and the Food Safety Inspection Service of the US Depart-
ment of Agriculture) for use on retail food products.
The genome sizes of the chicken liver bacteriophages were esti-
mated to be 140 kb using PFGE, which places them as group III
Campylobacter bacteriophages (Loc Carrillo et al., 2007; Sails et al.,
1998). Recently a new sub-family of the T4-like phage super family,
the Eucampyvirinae, has been proposed for Campylobacter bacterio-
phages based on their genomic DNA sequences/sizes and particle
morphologies (Javed et al., 2014). Group III bacteriophagesrichment
Heart Spleen Breast meat Kidney
1/6 (17%) 0/6 (0%) 0/6 (0%) 0/6 (0%)
0/7 (0%) 0/7 (0%) 0/7 (0%) 1/7 (14%)
1/7 (14%) 1/7 (14%) 0/7 (0%) 3/7 (43%)
0/7 (0%) 0/7 (0%) 0/7 (0%) 0/7 (0%)
0/7 (0%) 0/7 (0%) 0/7 (0%) 0/7 (0%)
Table 4
Prevalence and number of Campylobacter in livestock and poultry liver.
References Sample Frequency Samples contained N3.0 log CFU/g
This study Retail chicken liver surface 95/109 (87.2%) 3/109 (2.8%)
Retail chicken liver internal tissue 90/109 (82.6) 5/109 (4.6%)
Harrison et al. (2013) Chicken liver unfrozen 33/33 (100%) 30%
Chicken liver frozen 30/30 (100%) 7%
Whyte et al. (2006) Chicken liver surface 30/30 (100%) 30% (N1.1 × 103 MPN/sample)
Chicken liver internal tissue 27/30 (90%) 6% (N103 MPN/g)
Noormohamed and Fakhr (2013) Beef livers 39/50 (78%) NA
Noormohamed and Fakhr (2012) Chicken liver 122/159 (77%) NA
Strachan et al. (2012) Chicken liver 21/26 (81%) 25%
Cattle liver 22/32 (69%) 25%
Pig liver 23/29 (79%) 3%
Sheep liver 31/40 (78%) 10%
Kenar et al. (2009) Chicken liver surface 108/150 (72%) NA
Chicken liver internal tissue 30/150 (20%) NA
Cornelius et al. (2005) Sheep liver 180/272 (66%) 6.7% (N102 MPN/g or N30 cells/g)
126 A.S. Firlieyanti et al. / International Journal of Food Microbiology 237 (2016) 121–127constitute the genus Cp8unalikeviruses with genome sizes in the
range of 130–140 kb. The typing phages ɸ3 and ɸ15 used for phage
therapy in this study are group II but also fall within the
Eucampyvirinae as members of the genus CP220likeviruses.
CP220likeviruses and Cp8unalikeviruses have been used successful-
ly for active phage therapy in chickens against Campylobacters
(El-Shibiny et al., 2009; Loc Carrillo et al., 2005; Hammerl et al.,
2014; Scott et al., 2007), where there are sufﬁcient densities of host
bacteria to support phage replication (Cairns et al., 2009). Below
the phage proliferation threshold requires that the bacteriophage
encounter, adsorb and inundate the target bacteria - a process that
has an intrinsic requirement for high phage titres. It is likely that
some phages are better suited to this purpose in terms of achieving
high titres, maintaining stability and retaining activity. In this appli-
cation the phage titres applied to chicken liver would have to remain
high at retail and post disruption of the liver when internalised bac-
teria may become accessible for phage lysis.
Details of the mechanisms involved in the intestinal colonisation of
chickens are few but even less is known regarding how the liver may
become colonised. Oral administration of the liver isolates to broiler
chickens results in efﬁcient intestinal colonisation but this does not
guarantee liver colonisation. However, C. jejuni CLB104 could be recov-
ered from the livers of some of the chickens, whereas the control C.
jejuni strains remained within the intestine of all the birds to which
they were administered. Jennings et al. (2011) examined the incidence
of focal lesions in the livers of commercial broiler chickens as a charac-
teristic of the disease vibrionic hepatitis. These authors noted that livers
showing focal lesions were more likely to have greater Campylobacter
content than those without but were unable to replicate the disease in
healthy chickens inoculated with the liver isolates. However, that
Campylobacters could colonise the livers of these chickens is of signiﬁ-
cance given the association of chicken liver with foodborne disease.
More recently it has been reported that vibrionic hepatitis (spotty
liver disease) in laying hens is associated with infection by a novel
Campylobacter species exhibiting a new sub-lineage of 16S rRNA
(Crawshaw et al., 2015). Campylobacter jejuni may not be the
aetiological agent of vibrionic hepatitis in chickens but the ability of
members of the species to cross the intestinal wall and reside in the
liver in signiﬁcant numbers within birds destined for retail represents
another route of exposure to the consumer.
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